Artículo especial
Información obligatoria que debe conocer un paciente con cáncer de próstata candidato a vigilancia activa
Obligatory Information that a Patient Diagnosed of Prostate Cancer and Candidate for an Active Surveillance Protocol must know
J. Rubio-Brionesa,
, I. Iborraa, M. Ramíreza, A. Calatravab, A. Colladoa, J. Casanovaa, J. Domínguez-Escriga, A. Gómez-Ferrera, J.V. Ricósa, J.L. Monrósa, R. Dumonta, J.A. López-Guerreroc, D. Salasd, E. Solsonaa
Autor para correspondencia
a Servicio de Urología, Instituto Valenciano de Oncología, Valencia, España
b Servicio de Anatomía Patológica, Instituto Valenciano de Oncología, Valencia, España
c Laboratorio de Biología Molecular, Instituto Valenciano de Oncología, Valencia, España
d Departamento de Salud Pública, Consellería de Sanidad, Generalitat Valenciana, Valencia, España
Leído
575
Vecesse ha leído el artículo
236
Total PDF
339
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 0 | 1 | 1 |
| 2025 9 | 0 | 1 | 1 |
| 2025 7 | 0 | 3 | 3 |
| 2025 6 | 0 | 3 | 3 |
| 2025 5 | 0 | 3 | 3 |
| 2025 1 | 0 | 1 | 1 |
| 2024 11 | 0 | 7 | 7 |
| 2024 10 | 0 | 1 | 1 |
| 2024 7 | 0 | 2 | 2 |
| 2024 4 | 0 | 1 | 1 |
| 2024 3 | 0 | 3 | 3 |
| 2024 1 | 0 | 2 | 2 |
| 2023 11 | 0 | 1 | 1 |
| 2023 10 | 0 | 3 | 3 |
| 2023 9 | 0 | 1 | 1 |
| 2023 8 | 0 | 1 | 1 |
| 2023 7 | 0 | 5 | 5 |
| 2023 6 | 0 | 2 | 2 |
| 2023 5 | 0 | 1 | 1 |
| 2023 4 | 0 | 2 | 2 |
| 2023 3 | 1 | 0 | 1 |
| 2022 1 | 0 | 1 | 1 |
| 2022 12 | 0 | 5 | 5 |
| 2022 11 | 0 | 8 | 8 |
| 2022 10 | 0 | 9 | 9 |
| 2022 9 | 0 | 1 | 1 |
| 2022 8 | 0 | 3 | 3 |
| 2022 6 | 0 | 3 | 3 |
| 2022 5 | 0 | 2 | 2 |
| 2022 4 | 0 | 5 | 5 |
| 2022 3 | 0 | 4 | 4 |
| 2021 1 | 0 | 3 | 3 |
| 2021 12 | 0 | 6 | 6 |
| 2021 11 | 0 | 2 | 2 |
| 2021 10 | 0 | 2 | 2 |
| 2021 9 | 0 | 3 | 3 |
| 2021 8 | 0 | 3 | 3 |
| 2021 7 | 0 | 3 | 3 |
| 2021 5 | 0 | 1 | 1 |
| 2021 4 | 0 | 1 | 1 |
| 2021 3 | 0 | 3 | 3 |
| 2021 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 3 | 3 |
| 2020 12 | 0 | 6 | 6 |
| 2020 11 | 0 | 1 | 1 |
| 2020 10 | 0 | 1 | 1 |
| 2020 9 | 0 | 2 | 2 |
| 2020 8 | 1 | 5 | 6 |
| 2020 6 | 0 | 2 | 2 |
| 2020 4 | 0 | 1 | 1 |
| 2019 12 | 0 | 1 | 1 |
| 2019 10 | 0 | 1 | 1 |
| 2019 8 | 1 | 2 | 3 |
| 2019 6 | 0 | 12 | 12 |
| 2019 5 | 0 | 13 | 13 |
| 2019 2 | 1 | 2 | 3 |
| 2018 12 | 1 | 0 | 1 |
| 2018 9 | 1 | 0 | 1 |
| 2018 8 | 1 | 0 | 1 |
| 2018 4 | 1 | 0 | 1 |
| 2018 2 | 5 | 0 | 5 |
| 2018 1 | 11 | 0 | 11 |
| 2017 12 | 10 | 0 | 10 |
| 2017 11 | 17 | 1 | 18 |
| 2017 10 | 17 | 1 | 18 |
| 2017 9 | 17 | 2 | 19 |
| 2017 8 | 17 | 0 | 17 |
| 2017 7 | 18 | 1 | 19 |
| 2017 6 | 21 | 2 | 23 |
| 2017 5 | 22 | 1 | 23 |
| 2017 4 | 28 | 1 | 29 |
| 2017 3 | 17 | 2 | 19 |
| 2017 2 | 12 | 2 | 14 |
| 2016 1 | 4 | 3 | 7 |
| 2016 12 | 33 | 10 | 43 |
| 2016 11 | 45 | 9 | 54 |
| 2016 10 | 2 | 0 | 2 |
| 2016 9 | 0 | 2 | 2 |
| 2016 7 | 0 | 1 | 1 |
| 2016 6 | 0 | 1 | 1 |
| 2016 5 | 1 | 2 | 3 |
| 2016 2 | 0 | 1 | 1 |
| 2015 12 | 0 | 5 | 5 |
| 2015 11 | 1 | 2 | 3 |
| 2015 10 | 0 | 3 | 3 |
| 2015 7 | 0 | 1 | 1 |
| 2015 6 | 2 | 2 | 4 |
| 2015 5 | 0 | 1 | 1 |
| 2015 4 | 4 | 1 | 5 |
| 2015 3 | 1 | 0 | 1 |
| 2015 2 | 3 | 0 | 3 |
| 2015 1 | 5 | 3 | 8 |
| 2014 12 | 4 | 1 | 5 |
| 2014 11 | 13 | 9 | 22 |
| 2014 10 | 1 | 1 | 2 |
Mostrar todo
